R3 Stem Cell has been named Top 10 Biotech Startups 2021 by Life Sciences Review. This continues a plethora of Awards that R3 has received over the past years.

People ask us frequently how we can offer such high cell counts at pricing so low. We dont sacrifice the quality of our biologics, we use our volume buying power to pass savings along to patients.

CEO David Greene, MD, PhD, MBA

SCOTTSDALE, ARIZONA, UNITED STATES, July 29, 2021 /EINPresswire.com/ R3 Stem Cell was recently named to Top 10 Biotech Startups 2021 by Life Sciences Review. This continues a plethora of Awards that R3 has been receiving over the past few years including best USA Regenerative Therapy Company, Most Innovative, Fastest Growing and more.

Excerpt from:

R3 Stem Cell & Exosome Therapy: Joint & Back Pain, Avoid ...

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh